CORRECTION article

Front. Oncol., 02 September 2025

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1654169

Correction: Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment

  • 1. Department of Basic Medical Sciences, Qinghai University Medical College, Xining, Qinghai, China

  • 2. Department of Medical Laboratory, Qinghai Provincial People’s Hospital, Xining, Qinghai, China

  • 3. State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining, Qinghai, China

  • 4. Research Center for High Altitude Medicine, Qinghai University, Xining, Qinghai, China

  • 5. Key Laboratory of the Ministry of High Altitude Medicine, Qinghai University, Xining, Qinghai, China

There was a mistake in Figure 1B as published. The figure contains an error caused by an unintentional assembly mistake: while adjusting the layout to keep the spacing and formatting uniform, we duplicated a placeholder image that inadvertently overwrote the correct panel, resulting in incorrect image usage. The corrected Figure 1 and its caption appear below.

Figure 1

There was a mistake in Figure 4B as published. The figure contains an error due to an unintentional mistake during assembly, where the “4T1-Invasion-Dig” image was overwritten by the “MDA-MB-231-Invasion-AA” image, resulting in incorrect image usage. The corrected Figure 4 and its caption appear below.

Figure 4

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

immune checkpoint blockade, triple-negative breast cancer, malignant phenotype, nanos1, PD-1 inhibitors, tumor microenvironments

Citation

Wang T, Lei Y, Sun J, Wang L, Lin Y, Wu Z, Zhang S, Cao C and Wang H (2025) Correction: Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment. Front. Oncol. 15:1654169. doi: 10.3389/fonc.2025.1654169

Received

26 June 2025

Accepted

19 August 2025

Published

02 September 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2025

Updates

Copyright

*Correspondence: Haiyan Wang,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics